Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Mattia, Kimberly ^a   Puffer, Bridget A ^a   Williams, Katherine L ^b   Gonzalez, Ritela ^b   Murray, Meredith ^a   Sluzas, Emily ^a   Pagano, Dan ^a   Ajith, Sandya ^a   Bower, Megan ^a   Berdougo, Eli ^a   Harris, Eva ^b   Doranz, Benjamin J ^a  

^a Integral Molecular Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VIRUS ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ANTIGENICITY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; DENGUE; DENGUE VIRUS; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; INCUBATION TEMPERATURE; INFANT; MEASUREMENT; PRESCHOOL CHILD; REPRODUCIBILITY; SAFETY; SEROTYPE; VIRUS NEUTRALIZATION; VIRUS PARTICLE; CELL LINE; GENETICS; IMMUNOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRION;

DENGUE VIRUS;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELL LINE; DENGUE VIRUS; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRION;

EID: 80655132058     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027252     Document Type: Article

References (34)

1. Clyde K, Kyle JL, Harris E, (2006) Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80: 11418-11431.
2. Mackenzie JS, Gubler DJ, Petersen LR, (2004) Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med 10: S98-109.
3. Adams B, Holmes EC, Zhang C, Mammen MP Jr, Nimmannitya S, et al. (2006) Cross-protective immunity can account for the alternating epidemic pattern of dengue virus serotypes circulating in Bangkok. Proc Natl Acad Sci U S A 103: 14234-14239.
4. Rothman AL, (2004) Dengue: defining protective versus pathologic immunity. J Clin Invest 113: 946-951.
5. Russell PK, Nisalak A, (1967) Dengue virus neutralization by the plaque reduction neutralization test. J Immunol 99: 291-294.
6. Kraus AA, Messer W, Haymore LB, de Silva AM, (2007) Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J Clin Microbiol 45: 3777-3780.
7. Putnak JR, de la Barrera R, Burgess T, Pardo J, Dessy F, et al. (2008) Comparative evaluation of three assays for measurement of dengue virus neutralizing antibodies. Am J Trop Med Hyg 79: 115-122.
8. Shanaka WW, Rodrigo I, Alcena DC, Rose RC, Jin X, et al. (2009) An automated Dengue virus microneutralization plaque assay performed in human Fc{gamma} receptor-expressing CV-1 cells. Am J Trop Med Hyg 80: 61-65.
9. Gehrke R, Ecker M, Aberle SW, Allison SL, Heinz FX, et al. (2003) Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line. J Virol 77: 8924-8933.
10. Harvey TJ, Liu WJ, Wang XJ, Linedale R, Jacobs M, et al. (2004) Tetracycline-inducible packaging cell line for production of flavivirus replicon particles. J Virol 78: 531-538.
11. Jones CT, Patkar CG, Kuhn RJ, (2005) Construction and applications of yellow fever virus replicons. Virology 331: 247-259.
12. Lai CY, Hu HP, King CC, Wang WK, (2008) Incorporation of dengue virus replicon into virus-like particles by a cell line stably expressing precursor membrane and envelope proteins of dengue virus type 2. J Biomed Sci 15: 15-27.
13. Pierson TC, Diamond MS, Ahmed AA, Valentine LE, Davis CW, et al. (2005) An infectious West Nile virus that expresses a GFP reporter gene. Virology 334: 28-40.
14. Ansarah-Sobrinho C, Nelson S, Jost CA, Whitehead SS, Pierson TC, (2008) Temperature-dependent production of pseudoinfectious dengue reporter virus particles by complementation. Virology 381: 67-74.
15. Dowd KA, Jost CA, Durbin AP, Whitehead SS, Pierson TC, A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus. PLoS Pathog 7: e1002111.
16. Davis CW, Nguyen HY, Hanna SL, Sanchez MD, Doms RW, et al. (2006) West Nile virus discriminates between DC-SIGN and DC-SIGNR for cellular attachment and infection. J Virol 80: 1290-1301.
17. Martin NC, Pardo J, Simmons M, Tjaden JA, Widjaja S, et al. (2006) An immunocytometric assay based on dengue infection via DC-SIGN permits rapid measurement of anti-dengue neutralizing antibodies. J Virol Methods 134: 74-85.
18. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, et al. (2003) DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 197: 823-829.
19. Pohlmann S, Soilleux EJ, Baribaud F, Leslie GJ, Morris LS, et al. (2001) DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc Natl Acad Sci U S A 98: 2670-2675.
20. Gentry MK, Henchal EA, McCown JM, Brandt WE, Dalrymple JM, (1982) Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. Am J Trop Med Hyg 31: 548-555.
21. Henchal EA, Gentry MK, McCown JM, Brandt WE, (1982) Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence. Am J Trop Med Hyg 31: 830-836.
22. Pierson TC, Sanchez MD, Puffer BA, Ahmed AA, Geiss BJ, et al. (2006) A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346: 53-65.
23. WHO Report (2005) Report of a collaborative study to assess the suitability of candidate reference material to serve as the first WHO reference reagent of dengue virus antibody and to standardize the neurtalization test for denge viruses.
24. Halstead SB, Rojanasuphot S, Sangkawibha N, (1983) Original antigenic sin in dengue. Am J Trop Med Hyg 32: 154-156.
25. Thomas SJ, Nisalak A, Anderson KB, Libraty DH, Kalayanarooj S, et al. (2009) Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance. Am J Trop Med Hyg 81: 825-833.
26. Endy TP, Nisalak A, Chunsuttitwat S, Vaughn DW, Green S, et al. (2004) Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 189: 990-1000.
27. Henchal EA, Putnak JR, (1990) The dengue viruses. Clin Microbiol Rev 3: 376-396.
28. Halstead SB, (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239: 476-481.
29. Halstead SB, O'Rourke EJ, (1977) Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265: 739-741.
30. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS, (1989) Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 40: 444-451.
31. Puffer BA, Mattia K, (2010) Flavivirus reporter virus and methods of making and using the same. US Pat #12/942,632.
32. Colbert JA, Gordon A, Roxelin R, Silva S, Silva J, et al. (2007) Ultrasound measurement of gallbladder wall thickening as a diagnostic test and prognostic indicator for severe dengue in pediatric patients. Pediatr Infect Dis J 26: 850-852.
33. Rocha C, Silva S, Gordon A, Hammond SN, Elizondo D, et al. (2009) Improvement in hospital indicators after changes in dengue case management in Nicaragua. Am J Trop Med Hyg 81: 287-292.
34. Harris E, Videa E, Perez L, Sandoval E, Tellez Y, et al. (2000) Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 63: 5-11.